• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凋亡相关基因介导的细胞死亡模式诱导胃癌的免疫抑制和免疫治疗抵抗

Apoptosis-Related Gene-Mediated Cell Death Pattern Induces Immunosuppression and Immunotherapy Resistance in Gastric Cancer.

作者信息

Yuan Xiaolu, Zhou Jun, Zhou Liping, Huang Zudong, Wang Weiwei, Qiu Jiasheng, Yang Qiangbang, Zhang Chaohao, Ma MingHui

机构信息

Department of Pathology, Maoming People's Hospital, Maoming, China.

Department of Gastrointestinal Surgery, Maoming People's Hospital, Maoming, China.

出版信息

Front Genet. 2022 Jul 5;13:921163. doi: 10.3389/fgene.2022.921163. eCollection 2022.

DOI:10.3389/fgene.2022.921163
PMID:35865012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9295743/
Abstract

Apoptosis is a type of cell death, which can produce abundant mediators to modify the tumor microenvironment. However, relationships between apoptosis, immunosuppression, and immunotherapy resistance of gastric cancer (GC) remain unclear. Gene expression data and matching clinical information were extracted from TCGA-STAD, GSE84437, GSE34942, GSE15459, GSE57303, ACRG/GSE62254, GSE29272, GSE26253, and IMvigor210 datasets. A consensus clustering analysis based on six apoptosis-related genes (ARGs) was performed to determine the molecular subtypes, and then an apoptosisScore was constructed based on differentially expressed and prognostic genes between molecular subtypes. Estimate R package was utilized to calculate the tumor microenvironment condition. Kaplan-Meier analysis and ROC curves were performed to further confirm the apoptosisScore efficacy. Based on six ARGs, two molecular subgroups with significantly distinct survival and immune cell infiltration were identified. Then, an apoptosisScore was built to quantify the apoptosis index of each GC patient. Next, we investigated the correlations between the clinical characteristics and apoptosisScore using logistic regression. Multivariate Cox analysis shows that low apoptosisScore was an independent predictor of poor overall survival in TCGA and ACRG datasets, and was associated with the higher pathological stage. Meanwhile, low apoptosisScore was associated with higher immune cell, higher ESTIMATEScore, higher immuneScore, higher stromalScore, higher immune checkpoint, and lower tumorpurity, which was consistent with the "immunity tidal model theory". Importantly, low apoptosisScore was sensitive to immunotherapy. In addition, GSEA indicated that several gene ontology and Kyoto Encyclopedia of Genes and Genomes items associated with apoptosis, several immune-related pathways, and JAK-STAT signal pathway were considerably enriched in the low apoptosisScore phenotype pathway. Our findings propose that low apoptosisScore is a prognostic biomarker, correlated with immune infiltrates, and sensitivity to immunotherapy in GC.

摘要

细胞凋亡是一种细胞死亡类型,它能产生大量介质来改变肿瘤微环境。然而,胃癌(GC)的细胞凋亡、免疫抑制和免疫治疗耐药性之间的关系仍不清楚。从TCGA-STAD、GSE84437、GSE34942、GSE15459、GSE57303、ACRG/GSE62254、GSE29272、GSE26253和IMvigor210数据集中提取基因表达数据和匹配的临床信息。基于六个凋亡相关基因(ARG)进行共识聚类分析以确定分子亚型,然后基于分子亚型之间差异表达和预后基因构建凋亡评分(apoptosisScore)。利用Estimate R包计算肿瘤微环境状况。进行Kaplan-Meier分析和ROC曲线以进一步确认凋亡评分的有效性。基于六个ARG,鉴定出两个生存和免疫细胞浸润明显不同的分子亚组。然后,构建凋亡评分以量化每个GC患者的凋亡指数。接下来,我们使用逻辑回归研究临床特征与凋亡评分之间的相关性。多变量Cox分析表明,低凋亡评分是TCGA和ACRG数据集中总生存期差的独立预测因子,且与更高的病理分期相关。同时,低凋亡评分与更高的免疫细胞、更高的ESTIMATEScore、更高的免疫评分、更高的基质评分、更高的免疫检查点和更低的肿瘤纯度相关,这与“免疫潮汐模型理论”一致。重要的是,低凋亡评分对免疫治疗敏感。此外,基因集富集分析(GSEA)表明,与凋亡相关的几个基因本体和京都基因与基因组百科全书条目、几个免疫相关途径以及JAK-STAT信号通路在低凋亡评分表型途径中显著富集。我们的研究结果表明,低凋亡评分是一种预后生物标志物,与免疫浸润相关,且对GC免疫治疗敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/c0b93c3b3565/fgene-13-921163-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/4cdc9e4d963c/fgene-13-921163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/3e4c28735260/fgene-13-921163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/3afea84cafcf/fgene-13-921163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/532586482e81/fgene-13-921163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/58469bf4e773/fgene-13-921163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/96d9b8bc7f54/fgene-13-921163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/052d080491d0/fgene-13-921163-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/00552401ec24/fgene-13-921163-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/1d80b9d4f01f/fgene-13-921163-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/c0b93c3b3565/fgene-13-921163-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/4cdc9e4d963c/fgene-13-921163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/3e4c28735260/fgene-13-921163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/3afea84cafcf/fgene-13-921163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/532586482e81/fgene-13-921163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/58469bf4e773/fgene-13-921163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/96d9b8bc7f54/fgene-13-921163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/052d080491d0/fgene-13-921163-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/00552401ec24/fgene-13-921163-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/1d80b9d4f01f/fgene-13-921163-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bd4/9295743/c0b93c3b3565/fgene-13-921163-g010.jpg

相似文献

1
Apoptosis-Related Gene-Mediated Cell Death Pattern Induces Immunosuppression and Immunotherapy Resistance in Gastric Cancer.凋亡相关基因介导的细胞死亡模式诱导胃癌的免疫抑制和免疫治疗抵抗
Front Genet. 2022 Jul 5;13:921163. doi: 10.3389/fgene.2022.921163. eCollection 2022.
2
Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma.Notch 通路相关基因介导的致癌信号通路诱导肝癌免疫抑制和免疫治疗耐药。
Immunogenetics. 2022 Dec;74(6):539-557. doi: 10.1007/s00251-022-01273-6. Epub 2022 Jul 27.
3
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.结肠癌中缺氧相关亚型的鉴定、预后模型的建立及肿瘤微环境浸润特征
Front Genet. 2022 Jun 17;13:919389. doi: 10.3389/fgene.2022.919389. eCollection 2022.
4
Immunotherapy Efficacy-related Risk Classifier Differentiate Prognostic Characteristics of Gastric Cancer-A Large-scale Retrospective Study.免疫治疗疗效相关风险分类器可区分胃癌的预后特征——一项大规模回顾性研究。
J Immunother. 2023 Oct 1;46(8):323-332. doi: 10.1097/CJI.0000000000000481. Epub 2023 Jul 19.
5
Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer.基于胃癌免疫微环境的预后特征构建与验证
Front Surg. 2023 Mar 31;10:1088292. doi: 10.3389/fsurg.2023.1088292. eCollection 2023.
6
Activated CD4 T cells/Tregs derived immune-metabolism signature provide precise prognosis assessment for gastric cancer and beneficial for treatment option.活化的CD4 T细胞/调节性T细胞衍生的免疫代谢特征可为胃癌提供精确的预后评估,并有助于治疗方案的选择。
Heliyon. 2024 Feb 1;10(3):e25463. doi: 10.1016/j.heliyon.2024.e25463. eCollection 2024 Feb 15.
7
Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer.凋亡相关基因介导的分子亚型描绘了膀胱癌肿瘤微环境的特征,并指导免疫治疗。
BMC Med Genomics. 2023 Apr 28;16(1):88. doi: 10.1186/s12920-023-01525-8.
8
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.晚期胃癌肿瘤微环境的免疫景观鉴定免疫治疗相关基因特征。
BMC Cancer. 2021 Dec 11;21(1):1324. doi: 10.1186/s12885-021-09065-z.
9
Application of apoptosis-related genes in a multiomics-related prognostic model study of gastric cancer.凋亡相关基因在胃癌多组学相关预后模型研究中的应用
Front Genet. 2022 Aug 5;13:901200. doi: 10.3389/fgene.2022.901200. eCollection 2022.
10
FKBP10 Acts as a New Biomarker for Prognosis and Lymph Node Metastasis of Gastric Cancer by Bioinformatics Analysis and in Vitro Experiments.通过生物信息学分析和体外实验,FKBP10作为胃癌预后和淋巴结转移的新生物标志物
Onco Targets Ther. 2020 Jul 28;13:7399-7409. doi: 10.2147/OTT.S253154. eCollection 2020.

引用本文的文献

1
Integrating multiomics analysis and machine learning to refine the molecular subtyping and prognostic analysis of stomach adenocarcinoma.整合多组学分析与机器学习以优化胃腺癌的分子亚型分类和预后分析。
Sci Rep. 2025 Jan 30;15(1):3843. doi: 10.1038/s41598-025-87444-3.
2
Identification of biomarkers related to infection for the diagnosis of gastrointestinal tumors applying machine learning methods.应用机器学习方法鉴定与感染相关的生物标志物用于胃肠道肿瘤的诊断
Heliyon. 2024 Nov 16;10(23):e40491. doi: 10.1016/j.heliyon.2024.e40491. eCollection 2024 Dec 15.
3
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer's Disease.

本文引用的文献

1
Synthesis, Characterization and Anticancer Efficacy Evaluation of Benzoxanthone Compounds toward Gastric Cancer SGC-7901.苯并蒽酮类化合物的合成、表征及对胃癌 SGC-7901 细胞的抗癌活性评价。
Molecules. 2022 Mar 18;27(6):1970. doi: 10.3390/molecules27061970.
2
Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.MeCP2 通过促进 PDK-1 转录激活 AKT 通路增加人胃癌对顺铂的耐药性。
Curr Cancer Drug Targets. 2022;22(5):414-425. doi: 10.2174/1568009622666220223115216.
3
Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis.
利用多样化的调控细胞死亡模式鉴定阿尔茨海默病的诊断生物标志物。
J Prev Alzheimers Dis. 2024;11(6):1775-1788. doi: 10.14283/jpad.2024.119.
4
RNA processing modification mediated subtypes illustrate the distinctive features of tumor microenvironment in hepatocellular carcinoma.RNA 加工修饰介导的亚型说明了肝癌肿瘤微环境的独特特征。
Genes Immun. 2024 Apr;25(2):132-148. doi: 10.1038/s41435-024-00265-8. Epub 2024 Mar 12.
5
Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer.凋亡相关基因介导的分子亚型描绘了膀胱癌肿瘤微环境的特征,并指导免疫治疗。
BMC Med Genomics. 2023 Apr 28;16(1):88. doi: 10.1186/s12920-023-01525-8.
获得紫杉醇耐药性会调节胃癌 AGS 细胞的生物学特性,并促进上皮间质转化和血管生成。
Naunyn Schmiedebergs Arch Pharmacol. 2022 May;395(5):515-533. doi: 10.1007/s00210-022-02217-3. Epub 2022 Feb 5.
4
Immunotherapy for gastric cancer: a 2021 update.胃癌的免疫治疗:2021 年更新。
Immunotherapy. 2022 Jan;14(1):41-64. doi: 10.2217/imt-2021-0103. Epub 2021 Nov 17.
5
Advances in clinical immunotherapy for gastric cancer.胃癌临床免疫治疗进展。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188615. doi: 10.1016/j.bbcan.2021.188615. Epub 2021 Aug 14.
6
Current treatment and recent progress in gastric cancer.胃癌的当前治疗方法和最新进展。
CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer.一种用于胃癌预后评估和辅助化疗选择的免疫检查点评分系统。
Nat Commun. 2020 Dec 11;11(1):6352. doi: 10.1038/s41467-020-20260-7.
9
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
10
Current status of immune checkpoint inhibitors for gastric cancer.胃癌免疫检查点抑制剂的现状。
Gastric Cancer. 2020 Jul;23(4):565-578. doi: 10.1007/s10120-020-01090-4. Epub 2020 May 28.